المؤلفون: Oporto Espuelas, Macarena, Burridge, Saskia, Kirkwood, Amy A, Bonney, Denise, Watts, Kelly, Shenton, Geoff, Jalowiec, Katarzyna A, O'Reilly, Maeve A, Roddie, Claire, Castleton, Anna, Clesham, Katherine, Nicholson, Emma, Alajangi, Rajesh, Prabhu, Shilpa, George, Lindsay, Uttenthal, Ben, Gabelli, Maria, Neill, Lorna, Besley, Caroline, Chaganti, Sridhar, Wynn, Robert F, Bartram, Jack, Chiesa, Robert, Lucchini, Giovanna, Pavasovic, Vesna, Rao, Anupama, Rao, Kanchan, Silva, Juliana, Samarasinghe, Sujith, Vora, Ajay, Clark, Peter, Cummins, Michelle, Marks, David I, Amrolia, Persis, Hough, Rachael, Ghorashian, Sara

المصدر: Blood Cancer Journal , 14 (1) , Article 66. (2024)

مصطلحات موضوعية: Child, Humans, Adolescent, Receptors, Chimeric Antigen, Intention to Treat Analysis, Retrospective Studies, Antigen, T-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Immunotherapy, Adoptive, Antigens, CD19

وصف الملف: text

العلاقة: https://discovery.ucl.ac.uk/id/eprint/10191202/2/Oporto%20Espuelas_Intention-to-treat%20outcomes%20utilising%20a%20stringent%20event%20definition%20in%20children%20and%20young%20people%20treated%20with%20tisagenlecleucel%20for%20r_r%20ALL%20through%20a%20national%20access%20scheme_VoR.pdfTest; https://discovery.ucl.ac.uk/id/eprint/10191202Test/

الإتاحة: https://discovery.ucl.ac.uk/id/eprint/10191202/2/Oporto%20Espuelas_Intention-to-treat%20outcomes%20utilising%20a%20stringent%20event%20definition%20in%20children%20and%20young%20people%20treated%20with%20tisagenlecleucel%20for%20r_r%20ALL%20through%20a%20national%20access%20scheme_VoR.pdfTest
https://discovery.ucl.ac.uk/id/eprint/10191202Test/

المؤلفون: Marks, David I, Castleton, Anna, Olavarria, Eduardo, Gilleece, Maria, Fielding, Adele, Mikhaeel, George, Beasley, Matthew, Diez, Patricia, Jackson, Aimee, Hodgkinson, Andrea, Elhanied, Mohamed, Chakraverty, Ronjon

مصطلحات موضوعية: Haematology (incl blood transfusion)

وصف الملف: text/html

العلاقة: http://bmjopen.bmj.com/cgi/content/short/13/6/e067790Test; http://dx.doi.org/10.1136/bmjopen-2022-067790Test

الإتاحة: https://doi.org/10.1136/bmjopen-2022-067790Test
http://bmjopen.bmj.com/cgi/content/short/13/6/e067790Test

المؤلفون: Marks, David I, Kirkwood, Amy A, Rowntree, Clare J, Aguiar, Melanie, Bailey, Katharine E, Beaton, Brendan, Cahalin, Paul, Castleton, Anna Z, Clifton-Hadley, Laura, Copland, Mhairi, Goldstone, Anthony H, Kelly, Richard, Lawrie, Emma, Lee, SooWah, McMillan, Andrew K, McMullin, Mary Frances, Menne, Tobias F, Mitchell, Rachel J, Moorman, Anthony V, Patel, Bela, Patrick, Pip, Smith, Paul, Taussig, David, Yallop, Deborah, Alapi, Krisztina Zuborne, Fielding, Adele K

المصدر: Lancet Haematology , 9 (4) e262-e275. (2022)

مصطلحات موضوعية: Adult, Aged, Antineoplastic Combined Chemotherapy Protocols, Female, Humans, Induction Chemotherapy, Male, Middle Aged, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor Cells, B-Lymphoid, Rituximab, State Medicine, Young Adult

وصف الملف: text

العلاقة: https://discovery.ucl.ac.uk/id/eprint/10146629/1/1-s2.0-S2352302622000382-main.pdfTest; https://discovery.ucl.ac.uk/id/eprint/10146629Test/

الإتاحة: https://discovery.ucl.ac.uk/id/eprint/10146629/1/1-s2.0-S2352302622000382-main.pdfTest
https://discovery.ucl.ac.uk/id/eprint/10146629Test/

المؤلفون: Moorman, Anthony V., Schwab, Claire, Winterman, Emily, Hancock, Jerry, Castleton, Anna, Cummins, Michelle, Gibson, Brenda, Goulden, Nick, Kearns, Pam, James, Beki, Kirkwood, Amy A., Lancaster, Donna, Madi, Mabrouk, McMillan, Andrew, Motwani, Jayashree, Norton, Alice, O’Marcaigh, Aengus, Patrick, Katharine, Bhatnagar, Neha, Qureshi, Amrana, Richardson, Deborah, Stokley, Simone, Taylor, Gordon, van Delft, Frederik W., Moppett, John, Harrison, Christine J., Samarasinghe, Sujith, Vora, Ajay

المساهمون: Bloodwise

المصدر: British Journal of Haematology ; volume 191, issue 5, page 844-851 ; ISSN 0007-1048 1365-2141

الإتاحة: https://doi.org/10.1111/bjh.17093Test

المؤلفون: Aref, Sarah, Castleton, Anna Z., Bailey, Katharine, Burt, Richard, Dey, Aditi, Leongamornlert, Daniel, Mitchell, Rachel J., Okasha, Dina, Fielding, Adele K.

المساهمون: King Abdullah International Medical Research Center

المصدر: Molecular Therapy ; volume 28, issue 4, page 1043-1055 ; ISSN 1525-0016

مصطلحات موضوعية: Drug Discovery, Pharmacology, Genetics, Molecular Biology, Molecular Medicine

الإتاحة: https://doi.org/10.1016/j.ymthe.2020.01.027Test
https://api.elsevier.com/content/article/PII:S1525001620300861?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S1525001620300861?httpAccept=text/plainTest

المؤلفون: Bozovic Spasojevic, Ivana, Ferrari, Andrea, De Munter, Johan, Gamble, Ashley, Konsoulova-Kirova, Assia, Rizvi, Katie, Schneider, Carina, Balsat, Marie, Castleton, Anna, Gofti-Laroche, Leila, Kienesberger, Anita, Timmermann, Beate, Vormoor, Josef, Saloustros, Emmanouil, Stark, Daniel P

المصدر: Tumori Journal; December 2023, Vol. 109 Issue: 6 p546-554, 9p

المؤلفون: Bozovic Spasojevic, I., Ferrari, A., De Munter, J., Gamble, A., Konsoulova-Kirova, A., Rizvi, K., Schneider, C., Balsat, M., Castleton, Anna, Gofti-Laroche, L., Kienesberger, A., Timmermann, B., Vormoor, J., Saloustros, E., Stark, D. P.

المساهمون: Medical Oncology Department, Institute for Oncology and Radiology of Serbia, Belgrade, Republic of Serbia

العلاقة: https://dx.doi.org/10.1177/03008916231183477Test; Bozovic Spasojevic I, Ferrari A, De Munter J, Gamble A, Konsoulova-Kirova A, Rizvi K, et al. Have we made progress in taking care of adolescents and young adults with cancer? Results of a European multi-professional survey. Tumori. 2023 Jul 24:3008916231183477. PubMed PMID: 37486101. Epub 2023/07/24. eng.; http://hdl.handle.net/10541/626471Test; Tumori

الإتاحة: https://doi.org/10.1177/03008916231183477Test
http://hdl.handle.net/10541/626471Test

المؤلفون: Hodder, A., Mishra, A. K., Clesham, K., Baird, S., Bhuller, K., Bisho, I., Bonney, D., Castleton, Anna, Cummins, M., Dickens, E., George, L., Ghorashian, S., Gibson, B., Hasley, C., Heaney, N., Hough, R. E., Ingham, D., Jigoulina, G., Lindsay, K., Lancaster, D., Madni, M., Malone, A., Mitchell, B., Moorman, A. V., Moppett, J., McLelland, V., Motwani, J., Nicholson, E., Osborne, C., Patrick, K., Samrin, L., Tewari, S., Thakur, I. R., Samarasinghe, S., Vora, A., O'Connor, D.

المساهمون: Department of Haematology, Great Ormond Street Hospital for Children, London

العلاقة: https://dx.doi.org/10.1182/blood-2022-162565Test; Hodder A, Mishra AK, Clesham K, Baird S, Bhuller K, Bisho I, et al. Reduced Intensity Reinduction Followed By Blinatumomab Achieves Excellent MRD Clearance with Reduced Toxicity and Facilitates Timely Transplant in Children and Young People with Relapsed B-Precursor Acute Lymphoblastic Leukemia. Blood. 2022 Nov;140:3268-70. PubMed PMID: WOS:000893223203136.; http://hdl.handle.net/10541/626121Test; Blood

الإتاحة: https://doi.org/10.1182/blood-2022-162565Test
http://hdl.handle.net/10541/626121Test

المؤلفون: Espuelas, M. O., Burridge, S., Bonney, D., Watts, K., Roddie, C., O'Reilly, M. A., Shenton, G., Snowden, J. A., Furness, C., Jalowiec, K. A. A., Neill, L., Clesham, K., Nicholson, E., Castleton, Anna, Patel, Amit, Besley, C., Wynn, R. F., Vora, A., Marks, D. I., George, L., Ben, U., Chaganti, S., Cummins, M., Amrolia, P. J., Hough, R. E., Ghorashian, S.

المساهمون: Molecular and Cellular Immunology Section, UCL Great Ormond Street Institute of Child Health, LONDON

العلاقة: https://dx.doi.org/10.1182/blood-2022-162863Test; Espuelas MO, Burridge S, Bonney D, Watts K, Roddie C, O'Reilly MA, et al. Systematic Intention to Treat Analysis of Real-World Outcomes in Children and Young Adults Receiving Tisagenlecleucel: From Elegibility through Treatment Failure. Blood. 2022 Nov;140:2408-10. PubMed PMID: WOS:000893223202172.; http://hdl.handle.net/10541/626119Test; Blood

الإتاحة: https://doi.org/10.1182/blood-2022-162863Test
http://hdl.handle.net/10541/626119Test

المؤلفون: Marks, D. I., Kirkwood, A. A., Rowntree, C. J., Aguiar, M., Bailey, K. E., Beaton, B., Cahalin, P., Castleton, Anna, Clifton-Hadley, L., Copland, M., Goldstone, A. H., Kelly, R., Lawrie, E., Lee, S., McMillan, A. K., McMullin, M. F., Menne, T. F., Mitchell, R. J., Moorman, A. V., Patel, B., Patrick, P., Smith, P., Taussig, D., Yallop, D., Alapi, K. Z., Fielding, A. K.

المساهمون: United Bristol Healthcare Trust, Bristol, UK

العلاقة: Marks DI, Kirkwood AA, Rowntree CJ, Aguiar M, Bailey KE, Beaton B, et al. Addition of four doses of rituximab to standard induction chemotherapy in adult patients with precursor B-cell acute lymphoblastic leukaemia (UKALL14): a phase 3, multicentre, randomised controlled trial. Lancet Haematology. 2022 Apr;9(4):E262-E75. PubMed PMID: WOS:000820773600013. Pubmed Central PMCID: 8969057 from Cancer Research UK, the Medical Research Council, and Servier; received consulting fees from Amgen; has a leadership/fiduciary role for the British Society of Haematology (unpaid); and is on a data safety and monitoring board for Novartis. AAK has received honoraria from Kite and Gilead; has received institutional peer-reviewed grant funding from Millennium pharmaceutics, Bristol Myers Squibb, Amgen, Celgene, Merck Sharp and Dohme, Janssen-Cilag, Pfizer, and Cancer Research UK; and is on a data safety and monitoring board or advisory committee for the University of Birmingham. AKM has received honoraria form Amgen, Roche, Abbvie, and Celgene; has received institutional peer-reviewed grant funding from Janssen and AstraZeneca; has received meeting support from Roche, Celgene, and Abbvie; and is on a data safety and monitoring board or advisory committee for Novartis. AVM has received institutional peer-reviewed grant funding from Cancer Research UK, Blood Cancer UK, the EU Innovative Medicines Initiative, and North East Children's Cancer Fund; has a leadership/fiduciary role for the ALLTogther Consortium Board and the Genetics Committee and Science Committee (unpaid); and has received honoraria from Amgen. AZC has received honoraria from Pfizer, Amgen, and Hartley Taylor; and is on a data safety and monitoring board or advisory committee for Pfizer. BB has received institutional peer-reviewed grant funding from Novartis/Haematology Society of Australia and New Zealand (New Investigator Scholarship). CJR has received honoraria from Kite; is on a data safety and monitoring board or advisory committee for Incyte, Gilead, and Pfizer; and has a leadership/fiduciary role as the National Cancer Research Institute Adult ALL Group Chair (unpaid). DIM has received consulting fees from Amgen, Pfizer, Kite, and Novartis; and honoraria from Amgen, Pfizer, and Kite. DY has received meetings support from Amgen, Servier, and Jazz; and is on a data safety and monitoring board or advisory committee for the University of Birmingham, Gilead, and Pfizer. KEB has received research grant support from Blood Cancer UK. LC-H has received institutional peer-reviewed grant funding from Millennium pharmaceutics, Bristol Myers Squibb, Amgen, Celgene., Merck Sharp and Dohme, Janssen-Cilag, Pfizer, and Cancer Research UK. MC has received institutional peer-reviewed grant funding from Cure Leukaemia, Blood Cancer UK, Cyclacel, and Incyte; has received consulting fees from Pfizer, Novartis, and Jazz; has received payment or honoraria from Pfizer, Novartis, Jazz, and Astellias; and has received meeting support from Novartis. PS has received institutional peer-reviewed grant funding from Cancer Research UK, Blood Cancer UK, and Servier. RK has received honoraria from Amgen and Pfizer; and is on a data safety and monitoring board or advisory committee for Amgen. TFM has received honoraria from Amgen, Pfizer, Kite, Gilead, Janssen, Roche, Servier, Novartis, and Celgene; has received institutional peer-reviewed grant funding from Janssen and AstraZeneca; and has received meeting support from Novartis, Amgen, Pfizer, Kite, Gilead, Celgene, Daiichi Sankyo, and Atara. All other authors declare no competing interests.; http://hdl.handle.net/10541/625494Test; Lancet Haematology

الإتاحة: http://hdl.handle.net/10541/625494Test